Effects of Ocrevus in Relapsing Multiple Sclerosis

NCT04387734 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Relapsing Multiple Sclerosis

Interventions

DRUG: Ocrelizumab
DRUG: Platform

Sponsor

Georgia State University

Collaborators

[object Object]